|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S3
|
$47,040
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
|
3R01CA227473-01S1
|
$293,469
|
HEROLD, KEVAN
|
YALE UNIVERSITY
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
3U54CA156734-08S1
|
$64,152
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
3P20CA221697-01S1
|
$47,364
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
3P20CA221697-02S1
|
$142,991
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-04S1
|
$62,420
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-04S2
|
$48,381
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
11th AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
|
1R13CA236113-01
|
$74,000
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
3P20CA202925-03S1
|
$104,165
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
2/2 The GUIDE Cancer Research Training Project
|
3P20CA202907-04S1
|
$48,872
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
3P20CA221696-02S1
|
$122,850
|
MCNEILL, LORNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
8th Great Lakes Nuclear Receptors Conference (GLNRC)
|
1R13CA236225-01
|
$5,000
|
DEHM, SCOTT
|
UNIVERSITY OF MINNESOTA
|
|
A biophysical approach to elucidating the molecular mechanisms of mitotic inhibitor targets
|
4K00CA223018-02
|
$80,244
|
MICKOLAJCZYK, KEITH
|
ROCKEFELLER UNIVERSITY
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
3R01CA174851-05S1
|
$119,204
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
A Mixed Methods Study to Explore the Effect of Hurricanes Irma and Maria on Cancer Care in Puerto Rico
|
1R21CA239456-01
|
$181,398
|
COLON, VIVIAN
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
A multi-fluorescent intravital microscopy approach to study osteosarcoma
|
7R21CA208618-02
|
$176,380
|
INTINI, GIUSEPPE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use
|
7R01CA207645-03
|
$575,548
|
OSBORNE, JOSEPH
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)
|
3R44CA165314-04S1
|
$1,400
|
LU, XUANYONG
|
IMCARE BIOTECH
|
|
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
|
4R44CA217591-02
|
$1,125,311
|
KAHN, STUART
|
SYNTRIX BIOSYSTEMS, INC.
|
|
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
|
3R44CA221513-02S1
|
$4,319
|
DEVENPORT, MARTIN
|
ONCOIMMUNE, INC.
|
|
A real-time, cost-effective, accurate UV measurement and sun protection system to prevent and reduce the incidence of sunburn in high-risk consumers.
|
4R44CA224658-02
|
$686,491
|
MEITL, MATTHEW
|
WEARIFI, INC.
|
|
A role for c-Abl/Arg in melanoma progression
|
3R01CA166499-05S1
|
$51,515
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
|
A Scalable Blood-based Pancreatic Cancer Test for High-Risk Screening
|
3R43CA213863-01A1S1
|
$2,000
|
FREEDMAN, DAVID
|
NANOVIEW DIAGNOSTICS, INC.
|
|
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
|
3R44CA176937-03S1
|
$210,000
|
LING, XIANG
|
CANGET BIOTEKPHARMA, LLC
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S2
|
$55,717
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S3
|
$65,235
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
ACADEMIC-INDUSTRIAL PARTNERSHIP FOR TRANSLATION OF PET/TRUS GUIDED INTERVENTION
|
7R01CA204254-03
|
$168,985
|
FEI, BAOWEI
|
UNIVERSITY OF TEXAS DALLAS
|
|
Administrative Supplement to Cancer Center Support Grant to Support Acquisition and Annotation of Biospecimens
|
3P30CA022453-36S5
|
$46,200
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations
|
3R33CA192980-03S2
|
$77,750
|
SALIPANTE, STEPHEN
|
UNIVERSITY OF WASHINGTON
|
|
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics
|
3U24CA194215-03S1
|
$79,500
|
XU, HUA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Affective Consequences of Chemotherapy
|
7R01CA194924-04
|
$396,867
|
DEVRIES, ANNE
|
WEST VIRGINIA UNIVERSITY
|
|
AIDS and Cancer Specimen Resource (ACSR)
|
3UM1CA181255-05S1
|
$3,000,000
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center
|
2U01CA096230-06
|
$718,223
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S1
|
$249,599
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S3
|
$250,067
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Corsortium
|
5U01CA121947-03
|
$3,732,363
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Consortium (AMC)
|
3UM1CA121947-12S2
|
$25,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
AN IMAGING-BASED APPROACH TO UNDERSTAND AND PREDICT CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY
|
3R01CA208623-02S3
|
$168,645
|
BEREZIN, MIKHAIL
|
WASHINGTON UNIVERSITY
|
|
Annual anal sampling using DNA screening to identify men who have sex with men at increased risk for anal cancer
|
7R01CA215403-02
|
$551,568
|
NYITRAY, ALAN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S3
|
$3,000
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
Assay Validation of Targeted RNA sequencing to Detect Kinase Gene Fusions
|
4UH3CA202971-02
|
$344,078
|
ROYCHOWDHURY, SAMEEK
|
OHIO STATE UNIVERSITY
|
|
Assessing the Intended and Unintended Consequences of E-cigarette TV Advertising
|
3R01CA194681-04S1
|
$143,363
|
HUANG, JIDONG
|
GEORGIA STATE UNIVERSITY
|
|
Avanzando Juntas: Adapting an evidence based weight loss program for Hispanic Breast Cancer Survivors
|
3R21CA215668-01A1S1
|
$42,563
|
STOLLEY, MELINDA
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Bay Area Team Against Resistance
|
3U54CA224081-01S1
|
$140,000
|
BIVONA, TREVER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
7R01CA182076-05
|
$339,622
|
ALLEN, PETER
|
DUKE UNIVERSITY
|
|
Blood metabolite profiles and risk of developing endometrial cancer
|
4R00CA218694-02
|
$249,000
|
PLAYDON, MARY
|
UNIVERSITY OF UTAH
|
|
Breaking the Obesity-Cancer Link: New Targets and Strategies
|
3R35CA197627-04S1
|
$82,611
|
HURSTING, STEPHEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Breast Cancer Family Registry Cohort
|
3U01CA164920-06S1
|
$149,999
|
TERRY, MARY BETH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|